Heterogeneous multimodal biomarkers analysis for Alzheimer’s disease via Bayesian network

[1]  J. Morris,et al.  Alzheimer’s Disease: The Challenge of the Second Century , 2011, Science Translational Medicine.

[2]  Irwin D Kuntz,et al.  Apolipoprotein (apo) E4 enhances amyloid beta peptide production in cultured neuronal cells: apoE structure as a potential therapeutic target. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[3]  H. Rusinek,et al.  Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer’s disease , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[4]  R. Kuljiš,et al.  Integrative Understanding of Emergent Brain Properties, Quantum Brain Hypotheses, and Connectome Alterations in Dementia are Key Challenges to Conquer Alzheimer's Disease , 2010, Front. Neur..

[5]  Y. Stern.  Cognitive reserve in ageing and Alzheimer's disease , 2012, The Lancet Neurology.

[6]  E. Boerwinkle,et al.  APOE genotype and cognitive decline in a middle-aged cohort , 2005, Neurology.

[7]  A. Goate,et al.  Alzheimer’s Disease Risk Genes and Mechanisms of Disease Pathogenesis , 2015, Biological Psychiatry.

[8]  Gregory F. Cooper,et al.  A Multivariate Discretization Method for Learning Bayesian Networks from Mixed Data , 1998, UAI.

[9]  Daoqiang Zhang,et al.  Multi-modal multi-task learning for joint prediction of multiple regression and classification variables in Alzheimer's disease , 2012, NeuroImage.

[10]  Y. Stern.  Cognitive Reserve and Alzheimer Disease , 2006, Alzheimer disease and associated disorders.

[11]  J. Hardy,et al.  Has the amyloid cascade hypothesis for Alzheimer's disease been proved? , 2006, Current Alzheimer research.

[12]  L M Bouter,et al.  Memory complaints and APOE-ε4 accelerate cognitive decline in cognitively normal elderly , 2001, Neurology.

[13]  Marco Scutari,et al.  Learning Bayesian Networks with the bnlearn R Package , 2009, 0908.3817.

[14]  Richard J. Caselli,et al.  Correlations between FDG PET glucose uptake-MRI gray matter volume scores and apolipoprotein E ε4 gene dose in cognitively normal adults: A cross-validation study using voxel-based multi-modal partial least squares , 2012, NeuroImage.

[15]  M Schwaiger,et al.  Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease , 2009, Neurology.

[16]  C. Jack,et al.  Comparison of 18F-FDG and PiB PET in Cognitive Impairment , 2009, Journal of Nuclear Medicine.

[17]  Michal Linial,et al.  Using Bayesian Networks to Analyze Expression Data , 2000, J. Comput. Biol..

[18]  Sandra E Black,et al.  Alzheimer's Disease, Cerebrovascular Disease, and the β-amyloid Cascade , 2012, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[19]  S. Sorbi,et al.  FDG PET and the genetics of dementia , 2013, Clinical and Translational Imaging.

[20]  Albert Hofman,et al.  Plasma clusterin and the risk of Alzheimer disease. , 2011, JAMA.

[21]  Jing Li,et al.  Heterogeneous data fusion for alzheimer's disease study , 2008, KDD.

[22]  Richard J. Caselli,et al.  Association between an Alzheimer’s Disease-Related Index and APOE ε4 Gene Dose , 2013, PloS one.

[23]  Nir Friedman,et al.  Discretizing Continuous Attributes While Learning Bayesian Networks , 1996, ICML.

[24]  I. Kuntz,et al.  Apolipoprotein ( apo ) E 4 enhances amyloid peptide production in cultured neuronal cells : ApoE structure as a potential therapeutic target , 2005 .

[25]  S. Lauritzen.  Propagation of Probabilities, Means, and Variances in Mixed Graphical Association Models , 1992 .

[26]  Daoqiang Zhang,et al.  Multimodal classification of Alzheimer's disease and mild cognitive impairment , 2011, NeuroImage.

[27]  Bogdan E. Popescu,et al.  PREDICTIVE LEARNING VIA RULE ENSEMBLES , 2008, 0811.1679.

[28]  Y. Stern,et al.  Cognitive reserve in aging. , 2011, Current Alzheimer research.

[29]  Gregory F. Cooper,et al.  Learning Hybrid Bayesian Networks from Data , 1999, Learning in Graphical Models.

[30]  A. Fagan,et al.  APOE predicts amyloid‐beta but not tau Alzheimer pathology in cognitively normal aging , 2010, Annals of neurology.

[31]  L. Mosconi,et al.  Glucose metabolism in normal aging and Alzheimer’s disease: methodological and physiological considerations for PET studies , 2013, Clinical and Translational Imaging.

[32]  Y. Stern.  What is cognitive reserve? Theory and research application of the reserve concept , 2002, Journal of the International Neuropsychological Society.

[33]  C. Jack,et al.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade , 2010, The Lancet Neurology.